Clinical Trials Browser

OTHER × Leukemia × Injections × Clear all

NCT04874480 2026-01-09

Tegavivint for the Treatment of Relapsed or Refractory Leukemia

Phase 1 Active not recruiting

Other hematologic neoplasm

Leukemia

NCT03904251 2023-11-18

CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute